Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma. - Wikidata - awgldk - TriplyDB

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.

http://www.wikidata.org/entity/Q33861071

about

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.

http://www.wikidata.org/entity/Q33861071

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.

@ast

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.

@en

type

label

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.

@ast

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.

@en

prefLabel

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.

@ast

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.

@en

P1433

Q33861071-0FEB85D3-A4A9-4080-9FF8-0165C6E4B21C

P1476

Q33861071-C31F7102-FFAA-42A7-BAB9-8D98005F3579

P2093

Q33861071-35AF8091-D67D-475C-B3D0-29874AEFFF8F

Q33861071-3FB0112C-C8C4-4222-AC59-212CEED293F3

Q33861071-469FB171-FEA2-448C-A88F-E968316923E1

Q33861071-8C4D0C7A-BB60-47E3-A1F7-62383D4967C8

Q33861071-A2DDB362-9BA8-4F83-B483-F1A5EE93360C

Q33861071-C4DBC602-B39C-4CA3-BEA1-43E4ED970146

P2860

Q33861071-07AF8EC7-6504-4105-86E0-4F859BB78619

Q33861071-0C050611-8AAC-4A5A-A967-1ADEBF19F9AA

Q33861071-20370E6A-96BF-4557-8880-25ED585CF8AF

Q33861071-34B561E8-0066-461E-8CBA-3A66FCEC7C53

Q33861071-355E7050-6209-4D24-86A2-359D1655E688

Q33861071-39C271BE-FB21-4359-B67A-947D8EC7DBA5

Q33861071-4037EF18-B99C-44CD-956B-3D1015F8EA86

Q33861071-4203581C-9132-4E6F-82B5-130B10BABF77

Q33861071-440B7B6C-1C9C-41CB-AAAF-EF365FED6BB8

Q33861071-58104A3C-3AA2-4474-B9F5-216172D3D2D5

P2888

Q33861071-BDE1B187-5925-4A40-8330-CCB1BC0389EA

P304

Q33861071-E8C080B4-BCB5-4B79-99A3-80FC5E6F957D

P31

Q33861071-3F0E268F-F2C4-4455-BA9D-D65A7EF24030

P356

Q33861071-666CAC41-F268-4ED6-8FAB-B38B40D175F5

P407

Q33861071-1452E2FD-8C7E-457B-A5AF-652DA71C9927

P433

Q33861071-D0013B39-E6FB-4549-95C0-CAD8459BBAB3

P478

Q33861071-A53ADED5-9ED3-4C3F-9A85-9FC63D2EB3FF

P50

Q33861071-56296F6A-B1B8-4A9C-9E57-1BFB1CC17287

Q33861071-EDB5DA25-E8D1-4F83-8E8B-FEEE494D0400

P577

Q33861071-5816F235-556B-40AF-B05B-BB8868CF4886

P6179

Q33861071-0E48F447-7C53-41F5-ADF9-5AA733C75BD9

P698

Q33861071-0B60A5CD-60C6-4926-A27F-429435C6255F

P932

Q33861071-98364888-8DCF-4331-BE63-679A46C323FE

P356

S41598-017-04495-X

P1433

Scientific Reports

P1476

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma

@en

P2093

Claire Dendle

http://www.w3.org/2001/XMLSchema#string

Michael Gilbertson

http://www.w3.org/2001/XMLSchema#string

Rhonda L Stuart

http://www.w3.org/2001/XMLSchema#string

Stephen Opat

http://www.w3.org/2001/XMLSchema#string

Tim Spelman

http://www.w3.org/2001/XMLSchema#string

Zoe McQuilten

http://www.w3.org/2001/XMLSchema#string

P2860

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.

Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study.

Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.

Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

P2888

s41598-017-04495-x

P304

4395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-04495-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1087309507

http://www.w3.org/2001/XMLSchema#string

P698

28667319

http://www.w3.org/2001/XMLSchema#string

P932

5493675

http://www.w3.org/2001/XMLSchema#string